Latest News and Press Releases

Aðalfundur Reita fasteignafélags hf. verður haldinn föstudaginn 11. mars 2022 kl. 11.00 í þingsal 2 á Icelandair Hotel Reykjavik Natura, Nauthólsvegi 52. Engar breytingar hafa orðið frá áður birtri...

German LNG Terminal in implementation phase with new shareholder structure Brunsbüttel / Hamburg, 5 March 2022 In view of current political developments and their impact on the...

SHENZHEN, China, March 05, 2022 (GLOBE NEWSWIRE) -- The Shenzhen Century Joint Innovation Technology Company Limited produces multi-functional portable OLED monitors by being mindful of today's...

05 March 2022 Fitch Downgrades Acron’s Credit Rating to «B» Fitch Ratings downgraded Acron's Long-term Issuer Default Rating (IDR) to 'B' from ‘BB-’ and placed ratings on Rating Watch Negative (RWN)...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lexicon Pharmaceuticals, Inc. (“Lexicon” or the “Company”) (NASDAQ: LXRX). Such investors...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cerence Inc. (“Cerence” or the “Company”) (NASDAQ: CRNC). Such investors are advised to...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Amryt Pharma plc (“Amryt” or the “Company”) (NASDAQ: AMYT). Such investors are advised to...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD).   Such investors are...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Finch Therapeutics Group, Inc. (“Finch” or the “Company”) (NASDAQ: FNCH). Such investors...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ: CELH).   Such investors are...